Review of microbiological sampling in diabetic foot disease
Keywords:diabetic foot, microbiology sampling, osteomyelitis
Introduction: Diabetes mellitus is a significant cause of morbidity and mortality. Foot-related complications affect 2–2.5% of people with diabetes. There is significant variation in outcomes for patients with diabetic foot disease within the UK. The multidisciplinary approach to diabetic foot disease is well publicised and protocols, guidance and consensus approaches exist for most components of the management of diabetic foot disease. Antimicrobial therapy to treat diabetic foot infections based on microbiological sampling and culture is well documented, but no consensus exists on how these samples should be obtained, processed and reported.
Methods: A literature review was undertaken to establish the reporting of techniques used in obtaining and processing microbiological samples in diabetic foot disease to establish if consensus exists in the methodologies used with a view to develop best practice guidelines.
Results: Six out of 102 papers reported all processes in obtaining and processing microbiological samples.
Conclusion: No gold standard consensus exists for microbiological sampling of diabetic foot infections, preventing optimisation of this aspect of management of diabetic foot disease and ultimately potentially adversely affecting the outcomes of this growing patient cohort.
Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018;138:271–81. https://doi.org/10.1016/j.diabres.2018.02.023
Kerr M. The cost of diabetic foot disease in England. Diabetic Foot J 2019;22(4):5–6.
Jeffcoate W, Barron E, Lomas J. Using data to tackle the burden of amputation in diabetes. Lancet 2017;390(10105):e29–e30. https://doi.org/10.1016/S0140-6736(17)32401-7
Jeffcoate W, Askey A, Berry A, et al. Do we know how good we all are at managing diabetic foot ulcers? A question for those who do not yet participate in the National Diabetes Foot Care Audit. Diabetic Foot J 2020;23(3):8–9.
National Institute for Health and Care Excellence. Diabetic foot problems: prevention and management. [NICE Guideline 19]. 2019. Available at: https://www.nice.org.uk/guidance/ng19 (accessed 10 March 2021).
Lipsky BA, Berendt AR, Cornia PB, et al. Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. J Am Podiatr Med Assoc 2013;103(1):2–7. https://doi.org/10.7547/1030002
Tone A, Nguyen S, Devemy F, et al. Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study. Diabetes Care 2015;38(2):302–7. https://doi.org/10.2337/dc14-1514
National Institute for Health and Care Excellence. Diabetic foot infection: antimicrobial prescribing. Evidence review. 2019. Available at: https://www.nice.org.uk/guidance/ng19/evidence/evidence-review-pdf-6953995118 (accessed 10 March 2021)
Dawson J, Travers HC, Wall ML. Level of training in microbiological sampling for toe amputations in diabetic foot disease: a survey of UK vascular trainees. Diabetic Foot J 2021 (accepted for publication).
Publish & Transfer of Copyright Agreement
For the mutual benefit and protection of the Author and the Journal Owner/Publisher it is necessary that the Author provides formal written Consent to Publish and Transfer of Copyright before publication of the Work.